Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Israeli occupation army: A sergeant from the 614th Combat Engineering Battalion was killed in the northern Gaza Strip on Thursday.
Israeli media: The government has approved the agreement that includes the release of hostages and Palestinian detainees amid divisions within the ministerial council.
European-Mediterranean Seismological Centre: The earthquake hit at a depth of 58 kilometers, warning of potentially hazardous tsunami waves.
European-Mediterranean Seismological Centre: A 7.4-magnitude earthquake strikes the Mindanao region in the Philippines.
Cuban Foreign Ministry: The clear objective of this escalation is to overthrow the constitutional government of President Nicolás Maduro and install a Washington-aligned authority.
Cuban Foreign Ministry: We warn against the growing escalation by the United States against the Bolivarian Republic of Venezuela.
Al Mayadeen's correspondent: Venezuela's request comes in response to the escalation of aggression and the unprecedented US military deployment in the Caribbean.
Al Mayadeen's correspondent: The Venezuelan government has officially requested an emergency meeting of the UN Security Council.
Al Mayadeen's correspondent: Israeli artillery shells the northwest of Nuseirat Camp in central Gaza Strip.
Israeli media: The ceasefire has come into effect.

Johnson & Johnson investigated in South Africa for high TB drug price

  • By Al Mayadeen English
  • Source: News websites
  • 22 Sep 2023 13:52
4 Min Read

South Africa records one of the highest TB rates in the world, and although it is curable, it ranks as the country’s top cause of death.

  • x
  • The number of tablets taken as part of the new treatment, which includes bedaquiline, as opposed to the old (AFP)
    The number of tablets taken as part of the new treatment, which includes bedaquiline (L), as opposed to the old (R). (AFP)

The US drugmaker Johnson & Johnson is being subject to an investigation by South Africa’s Competition Commission as a result of the high prices set for tuberculosis (TB) medicine named bedaquiline, in addition to its decision for its 20-year patent until 2027 to prevent cheaper generics from entering the country.

The investigation was revealed to the public at a media briefing of Médecins Sans Frontières (MSF) last week by the country's health department and the Health Justice Initiative (HJI) legal organization.

The patent refers to that for bedaquiline compounds in South Africa, which expired in July but was extended to 2027, prompting accusations against J&J of evergreening - which means when pharmaceutical manufacturers make trivial alterations to medicines or their applications to keep their monopoly on the market.

The founder, and director of HJI, Fatima Hassan, said, "The Competition Commission believes J&J could be in contravention of Section 8 of the Competition Act, which deals with excessive pricing and exclusionary conduct, which, in this case, refers to the practice of evergreening [because it results in excluding others from the market]," adding: "We believe this is unprecedented. We do not know of other investigations by the Competition Commission into a pharmaceutical company for evergreening."

It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.

In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility ("GDF")—the largest… pic.twitter.com/3pYy8AYhYW

— Johnson & Johnson (@JNJNews) July 12, 2023

Suffer more, pay more

South Africa records one of the highest TB rates in the world, and although it is curable, it ranks as the country’s top cause of death.

Related News

Trump threatens Spain’s NATO membership over defense spending dispute

US to deploy 200 troops to assist Israeli troops during Gaza ceasefire

Bedaquiline, alongside a combination of other drugs, intends to treat multidrug-resistant TB, which is not treatable with regular remedies. A gamechanger, bedaquiline challenges previous treatment, which consisted of two years of painful injections carrying side-effects, such as hearing loss and a high death rate.

The drug, required to be taken for a duration of six months, is already being given by the health department to the public in need since 2018.

'J&J prioritizes profit over needs of vulnerable'

Currently, the health department purchases the six-month course for each patient in need at 5,400 rand ($286), but starting October 1, when the new contract with the manufacturer begins, it will become 5,500 rand ($290). Meanwhile, nations that purchase it through the Stop TB partnership’s Global Drug Facility only pay around 2,446 rand ($129) - less than half. 

The Global Drug Facility uses pooled procurement for payment negotiation, which makes bargaining for lower prices for TB medicines possible, but those like South Africa, with open tender systems, are not legally able to purchase it through such systems.

Candice Sehoma of MSF expressed: "We are enraged to witness that J&J prioritizes profit over the needs of the most vulnerable populations in a country with a high burden of drug-resistant TB," urging "J&J to offer the same price of 2,446 rand for bedaquiline to the South African government as they have offered to countries that are part of the Global Drug Facility deal."

'Addressing health inequities'

Health activists have been calling for the past 10 years for a change in the legislation to contain evergreening.

Russell Rensburg, the director of the Rural Health Advocacy Project at Wits University in Johannesburg, explained: "Something for our legislators to consider is why we haven’t fixed our [patent] laws to ensure we don’t expose ourselves to these kinds of exploitative practices. Fixing the patent laws is essential to addressing health inequity."

In light of this, global leaders are partaking in a high-level discussion this week at the United Nations General Assembly in New York for the fight against TB, and discuss practices such as evergreening.

In its statement, the Competition Commission informed Johnson & Johnson of its investigation: "Johnson & Johnson is a longstanding and committed partner in South Africa’s fight against multidrug-resistant tuberculosis. Today, all patients in South Africa who require bedaquiline, our medicine for multidrug-resistant tuberculosis, have access to it thanks to our collaboration with the government of South Africa and other partners, which has contributed to a steady decline in TB incidence."

"We will continue to work collaboratively with our partners to ensure we can achieve our shared goal of ending TB," the company further said.

  • United States
  • Tuberculosis
  • South Africa
  • Johnson & Johnson

Most Read

A Hamas fighter in combat fatigues stands before the ceremony for the handover of Israeli captives to the Red Cross in Nuseirat, central Gaza Strip, Saturday, February 22, 2025 (AP)

Hamas responds to Trump plan, backs Gaza withdrawal, exchange

  • Politics
  • 3 Oct 2025
Mossad’s secret role in Aldo Moro’s 1978 murder revealed

Mossad’s secret role in Aldo Moro’s 1978 murder exposed

  • Politics
  • 5 Oct 2025
The Palestinian resistance and the people of Gaza showed that after combating Israeli aggression for two years, they remain victorious in the face of oppression (Mahdi Rteil/Al Mayadeen English)

Al-Aqsa Flood two years on, a tale of victory

  • Politics
  • 6 Oct 2025
President Donald Trump walks from Marine One after arriving on the South Lawn of the White House, Tuesday, Sept. 30, 2025, in Washington. (AP Photo/Alex Brandon)

Trump sets record-low refugee cap in new immigration policy shift

  • Politics
  • 4 Oct 2025

Coverage

All
In Five

Read Next

All
Displaced Palestinians watch smoke rise after Israeli military strikes as they gather on the coastal road near Wadi Gaza, in the central Gaza Strip, Thursday, October 9, 2025 (AP)
Politics

Israeli occupation bombs Gaza home, killing 4 and wounding 9

Israeli Prime Minister Benjamin Netanyahu and National Security Minister Itamar Ben-Gvir, right, visit the site of a shooting attack at a bus stop in al-Quds, Monday, September 8, 2025 (AP)
Politics

Ben-Gvir warns will topple Netanyahu’s govt over Hamas

Head of Hamas in Gaza Khalil al-Hayya speaks during an interview with AP, in Istanbul, Turkey, Wednesday, April 24, 2024 (AP)
Politics

Deal reached for permanent Gaza ceasefire, end to war: Al-Hayya

Yemeni Ansar Allah leader Sayyed Abdul-Malik al-Houthi during his speech on Thursday, Ocotber 9, 2025 (Yemeni Military Media)
Politics

Sayyed al-Houthi: Yemen on alert as Gaza ceasefire takes effect

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS